AKT1 and breast carcinoma: Given the important role of MAPKs and Akt in malignant breast cancer behavior and resistance to conventional treatments [157], targeting Ca2+ signaling using a channel blockade could also represent a useful therapeutic approach in tumors with such kinase alterations.